Sebi

IPO to include fresh issue and Offer For Sale, with funds allocated for debt repayment and expansion

Focused on regulated markets, Rubicon Research plans to use proceeds for debt repayment, strategic acquisitions, and corporate…

The company gears up for market debut with SEBI approval for Rs 800 Crore IPO

The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group…

Equipped with a US FDA approved facility for 6-Chloro-Hexane-2-One, the company can develop pharma intermediates and work with…

The two firms, which filed their preliminary papers with SEBI between June and September 2022, obtained their observation letters…

The issue with a face value of Re 1 per equity share is a complete Offer For Sale (OFS) aggregating to 20,925,652 equity shares by…

the company’s Initial Public Offering (IPO) comprises an offer for sale of 40,058,884 equity shares of face value Re 1 each by…

The letter is in regards to certain disclosures made by the company on the ongoing FDA audit of company's Unit-I and observations…

The company had filed its draft prospectus in December 2021